| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alkermes Plc (ALKS) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. ALKS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 225.5K | $11.05M | -2,034 | |
| VP | 109.2K | $5.35M | - | |
| VP | 69.4K | $3.40M | -9,000 | |
| Dir | 43.3K | $2.12M | -44,472 | |
| CFO | 36.7K | $1.80M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2016 | Biberstein Kathryn L | Evp/ Cao/ CCO Alks Inc; Sec Alks | Sale+OE | 15,000 | $56.13 | $841,988.91 | -15.1% | |
| Nov 30, 2016 | Landine Michael J | SVP, Corp Dev., Alkermes, Inc. | Sale+OE | 10,000 | $57.51 | $575,083.00 | -3.1% | |
| Nov 29, 2016 | Pops Richard F57 | Director And CEO, Alkermes Plc | Sale+OE | 30,000 | $56.98 | $1,709,469.25 | -2.4% | |
| Nov 22, 2016 | Pops Richard F57 | Director And CEO, Alkermes Plc | Sale+OE | 30,000 | $58.66 | $1,759,935.64 | -2.4% | |
| Nov 16, 2016 | Landine Michael J | SVP, Corp Dev., Alkermes, Inc. | Sale+OE | 10,000 | $58.59 | $585,900.80 | -3.1% | |
| Nov 15, 2016 | Pops Richard F57 | Director And CEO, Alkermes Plc | Sale+OE | 30,000 | $58.82 | $1,764,524.92 | -2.4% | |
| Nov 10, 2016 | Breyer Robert A | Director | Sell | 20,000 | $60.00 | $1,200,000.00 | -56.9% | |
| Nov 9, 2016 | Landine Michael J | SVP, Corp Dev., Alkermes, Inc. | Sale+OE | 10,000 | $56.22 | $562,183.19 | -2.0% | |
| Nov 8, 2016 | Pops Richard F57 | Director And CEO, Alkermes Plc | Sale+OE | 30,000 | $53.28 | $1,598,462.48 | -2.4% |